progenitor cell
Showing 1 - 25 of >10,000
Parkinson Disease Trial in Seoul (A9-DPC)
Recruiting
- Parkinson Disease
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 24, 2023
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Kidney Diseases Trial (endothelial progenitor cell)
Not yet recruiting
- Kidney Diseases
- endothelial progenitor cell
- (no location specified)
Jul 25, 2022
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)
Active, not recruiting
- Plasma Cell Myeloma
- Melphalan
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 21, 2022
Diabetic Neuropathies Trial in Frankfurt (Intraarterial bone marrow progenitor cell transplantation)
Completed
- Diabetic Neuropathies
- Intraarterial bone marrow progenitor cell transplantation
-
Frankfurt, GermanyDiv. of Cardiology and Vascular Medicine
Oct 18, 2021
Hypoplastic Left Heart Syndrome, Single Right Ventricle, Single Left Ventricle Trial in Okayama (Cardiac progenitor cell
Completed
- Hypoplastic Left Heart Syndrome
- +2 more
- Cardiac progenitor cell infusion
-
Okayama, JapanOkayama University
Nov 23, 2021
(LTFU) of Patients Treated With Genome-edited Autologous
Not yet recruiting
- Sickle Cell Disease
- OTQ923
- (no location specified)
Nov 24, 2023
Hypoplastic Left Heart Syndrome, Single Ventricle, Heart Failure Trial in Okayama (Autologous cardiac progenitor cell
Completed
- Hypoplastic Left Heart Syndrome
- +2 more
- Autologous cardiac progenitor cell transplantation
- staged shunt procedure
-
Okayama, JapanDepartment of Regenerative Medicine, Center for Innovative Clini
Nov 23, 2021
Sickle Cell Disease Trial in Duarte (Plerixafor)
Recruiting
- Sickle Cell Disease
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Retinitis Pigmentosa Trial in Beverly Hills (CNS10-NPC implantation)
Recruiting
- Retinitis Pigmentosa
- CNS10-NPC implantation
-
Beverly Hills, CaliforniaRetina-Vitreous Associates Medical Group
Dec 21, 2021
Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022
Diabetes, Type 2, Cardiovascular Diseases Trial in Washington (Dapagliflozin 10mg, Saxagliptin 5mg, Placebo Oral Tablet)
Terminated
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- Dapagliflozin 10mg
- +2 more
-
Washington, District of ColumbiaThe GW Medical Faculty Associates
Mar 21, 2022
Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)
Active, not recruiting
- Multiple Myeloma
- Amyloidosis
- Melphalan
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and
Recruiting
- Sickle Cell Disease
- hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
- hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 5, 2022
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Dilated Cardiomyopathy Trial in Okayama (CDC infusion)
Completed
- Dilated Cardiomyopathy
- CDC infusion
-
Okayama, JapanOkayama University Hospital
Nov 23, 2021
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Non-interventional, Long-term Safety Data Collection of Zarzio®
Active, not recruiting
- Hematopoietic Stem Cell Mobilization
-
Frankfurt/Main, Hessen, Germany
- +1 more
Jan 24, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Arterial Occlusive Diseases Trial in Frankfurt (intraarterial stem cell therapy, Stem cells)
Completed
- Arterial Occlusive Diseases
- intraarterial stem cell therapy
- Stem cells
-
Frankfurt, GermanyDiv. of Cardiology and Vascular Medicine
Oct 18, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,
Completed
- Acute Myeloid Leukemia
- +10 more
- total marrow irradiation
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021
Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection, Intrathecal saline injection)
Active, not recruiting
- Multiple Sclerosis
- Intrathecal MSC-NP injection
- Intrathecal saline injection
-
New York, New YorkTisch MS Research Center of New York
Oct 25, 2022